Novo Nordisk AS Newswire

Novo Nordisk AS Newswire

Comprehensive Real-Time News Feed for Novo Nordisk AS.

Results 1 - 20 of 641 in Novo Nordisk AS

  1. Fmr LLC Has $93.52 Million Holdings in Novo Nordisk A/SRead the original story w/Photo

    21 hrs ago | IntersportsWire

    Fmr LLC trimmed its position in shares of Novo Nordisk A/S by 57.2% during the second quarter, Holdings Channel reports. The fund owned 2,027,719 shares of the company's stock after selling 2,713,827 shares during the quarter.

    Comment?

  2. Danish News in Brief: Madsen trial to conclude on September...Read the original story w/Photo

    23 hrs ago | Copenhagen Post

    Proceedings were postponed last Friday, on what was supposed to be the final day of the appeal, after one of the lay judges needed medical attention. His absence meant the remaining judges - three professionals and one lay judge - could no longer make a binding judgment.

    Comment?

  3. Brokerages Expect Novo Nordisk A/S (NVO) to Post $0.61 Earnings Per ShareRead the original story w/Photo

    Tuesday | AmericanBankingNews.com

    Wall Street brokerages forecast that Novo Nordisk A/S will report $0.61 earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have made estimates for Novo Nordisk A/S's earnings.

    Comment?

  4. Danish pharma giant Novo Nordisk to open first Mass. officeRead the original story

    Tuesday | Business Journal

    Of the world's 20 largest drugmakers, 17 have a presence in Massachusetts. Novo Nordisk has been one of the three outliers - until now.

    Comment?

  5. UPDATE 1-Novo Nordisk lays off 400 staff in research & development unitRead the original story w/Photo

    Tuesday | Reuters

    Novo Nordisk, the world's top maker of diabetes drugs, said on Tuesday it will lay off 400 staff in Denmark and China in order to divert funding toward investment in biological and technological innovation. FILE PHOTO: The logo of Danish multinational pharmaceutical company Novo Nordisk is pictured on the facade of a production plant in Chartres, north-central France, April 21, 2016.

    Comment?

  6. Novo Nordisk lays off 400 staff in research & development unitRead the original story w/Photo

    Tuesday | Reuters

    Novo Nordisk, the world's top maker of diabetes drugs, said on Tuesday that it will lay off 400 staff in Denmark and China as part of a broader restructuring of its research and development organisation. The firm, which employs more than 42,000 people in 79 countries, has seen growth slow due to pricing pressures in the United States, from where it sources about half its revenue.

    Comment?

  7. 3 High-Quality Biotech Companies for 4th QuarterRead the original story w/Photo

    Monday Sep 17 | GuruFocus.com

    On Monday, GuruFocus' High Quality Screener listed three biotechnology companies that offer good potential ahead of the fourth quarter: Biogen Inc. , Gilead Sciences Inc. and Novo Nordisk A/S . Berkshire Hathaway Inc. CEO Warren Buffett has stressed several times that key investing criteria include predictable earnings and strong economic moat.

    Comment?

  8. All Penny Stocks.com News: Novo to Acquire Strategic Portfolio of...Read the original story

    Monday Sep 17 | SBWire

    AllPennyStocks.com Media, Inc. announces its latest article titled "Novo to Acquire Strategic Portfolio of Tenements in Western Australia, Shares Pop On News." Companies mentioned in this article include Novo Resources Corp. .

    Comment?

  9. Pressure intensifies on top drug lobbyist to fix 'doughnut hole' issueRead the original story w/Photo

    Friday Sep 14 | Washington Examiner

    Drug companies rarely lose in Washington, and the latest defeat will intensify pressure on the industry's top lobbying group at a time when the White House is fighting to reduce treatment costs. Reversing a provision in February's government funding bill that will effectively increase the portion of the cost of a brand-name drug that manufacturers must cover in Medicare Part D eclipses even pushback to the administration's efforts.

    Comment?

  10. First Republic Investment Management Inc. Trims Position in Novo Nordisk A/SRead the original story w/Photo

    Friday Sep 14 | AmericanBankingNews.com

    First Republic Investment Management Inc. lowered its stake in shares of Novo Nordisk A/S by 7.1% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 93,123 shares of the company's stock after selling 7,128 shares during the quarter.

    Comment?

  11. Novo Nordisk becomes latest to stockpile drugs ahead of BrexitRead the original story w/Photo

    Thursday Sep 13 | In-PharmaTechnologist.com

    Novo Nordisk joins a growing list of pharma companies that have announced plans to build a stockpile prior to the Brexit deadline. Shortly after the UK government advised all pharma companies with UK operations to stockpile six weeks' worth of drug supply, Novo Nordisk released a statement confirming it would be building stocks of insulin products.

    Comment?

  12. Van ECK Associates Corp Has $13.75 Million Holdings in Novo Nordisk A/SRead the original story w/Photo

    Sunday Sep 9 | AmericanBankingNews.com

    Van ECK Associates Corp grew its stake in Novo Nordisk A/S by 20.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 298,054 shares of the company's stock after acquiring an additional 50,777 shares during the quarter.

    Comment?

  13. Novo Nordisk A/S (NVO) Shares Bought by BB&T Securities LLCRead the original story w/Photo

    Saturday Sep 8 | AmericanBankingNews.com

    BB&T Securities LLC increased its stake in Novo Nordisk A/S by 7.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 291,422 shares of the company's stock after purchasing an additional 20,175 shares during the quarter.

    Comment?

  14. Sempre Health Raises USD 8M Series A to Improve Access to Medications across the USRead the original story w/Photo

    Friday Sep 7 | Newkerala.com

    SAN FRANCISCO: Sempre Health, the leading solution for behavior-based healthcare pricing, today announced the closing of its USD 8M series A financing. The funding round was led by Rethink Impact with participation from Social Capital and others.

    Comment?

  15. Stevens Capital Management LP Acquires Shares of 4,383 Novo Nordisk A/SRead the original story w/Photo

    Thursday Sep 6 | IntersportsWire

    Stevens Capital Management LP acquired a new position in Novo Nordisk A/S in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 4,383 shares of the company's stock, valued at approximately $202,000.

    Comment?

  16. Leading insulin manufacturer is stockpiling Four Months' supply to...Read the original story w/Photo

    Wednesday Sep 5 | Daily Mail

    Highway patrol officer shoots dead his Crossfit instructor wife and then himself after finding her locked inside a sports nutrition store with a male friend late at night Leading insulin manufacturer is stockpiling FOUR MONTHS' supply to protect diabetics after Brexit amid warnings the UK will run out if there is no deal Around 4.6 million people in the country are thought to have diabetes and many of them rely on insulin to stay healthy. Danish healthcare company Novo Nordisk supplies more than half of the UK's insulin and has revealed it's importing enough of the vital medication to last four months.

    Comment?

  17. Envestnet Asset Management Inc. Acquires 565,395 Shares of Novo Nordisk A/SRead the original story w/Photo

    Monday Sep 3 | AmericanBankingNews.com

    Envestnet Asset Management Inc. boosted its holdings in Novo Nordisk A/S by 943.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 625,349 shares of the company's stock after acquiring an additional 565,395 shares during the quarter.

    Comment?

  18. Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Novo Nordisk A/S (NVO) Stock PriceRead the original story w/Photo

    Sunday Sep 2 | IntersportsWire

    News headlines about Novo Nordisk A/S have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time.

    Comment?

  19. Novo Nordisk Could Benefit From Latest FDA WarningRead the original story w/Photo

    Sunday Sep 2 | Seeking Alpha

    The FDA recently issued a warning about the linking of Fournier's gangrene with SGLT2 inhibitors used in the treatment of type-2 diabetes. Novo Nordisk claims that its GLP-1 analogues are better at treating blood glucose levels for patients that are using the affecting drugs.

    Comment?

  20. Trading in Novo Nordisk shares by board members, executives and associated persons on 31 August 2018Read the original story

    Friday Aug 31 | P&T Community

    This document discloses the data of the transaction made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.

    Comment?